Numerous and different types of cancers possess the dysregulation of the mevalonate pathway as a common feature. Statins, traditionally applied in cardiovascular diseases to reduce lipid levels, subsequently have been discovered to exhibit anti-cancer activities also. Indeed, statins influence proliferation, migration, and survival of cancer cells by regulating crucial signaling proteins, such as Rho, Ras, and Rac. Recently, several studies have demonstrated that simvastatin, fluvastatin, and lovastatin are implicated in different pathways that enhance the survival time of patients with cancer under treatment in combination with antineoplastic agents. In this minireview, we present an overview of the most important studies conducted regarding the use of statins in cancer therapy up to date.

The innovative potential of statins in cancer: new targets for new therapies / Di Bello, Elisabetta; Zwergel, Clemens; Mai, Antonello; Valente, Sergio. - In: FRONTIERS IN CHEMISTRY. - ISSN 2296-2646. - 8:(2020). [10.3389/fchem.2020.00516]

The innovative potential of statins in cancer: new targets for new therapies

Di Bello, Elisabetta;Zwergel, Clemens;Mai, Antonello
;
Valente, Sergio
2020

Abstract

Numerous and different types of cancers possess the dysregulation of the mevalonate pathway as a common feature. Statins, traditionally applied in cardiovascular diseases to reduce lipid levels, subsequently have been discovered to exhibit anti-cancer activities also. Indeed, statins influence proliferation, migration, and survival of cancer cells by regulating crucial signaling proteins, such as Rho, Ras, and Rac. Recently, several studies have demonstrated that simvastatin, fluvastatin, and lovastatin are implicated in different pathways that enhance the survival time of patients with cancer under treatment in combination with antineoplastic agents. In this minireview, we present an overview of the most important studies conducted regarding the use of statins in cancer therapy up to date.
2020
cancer; statins; drug combination; target therapy; mevalonate pathway; HMG-CoA reductase
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
The innovative potential of statins in cancer: new targets for new therapies / Di Bello, Elisabetta; Zwergel, Clemens; Mai, Antonello; Valente, Sergio. - In: FRONTIERS IN CHEMISTRY. - ISSN 2296-2646. - 8:(2020). [10.3389/fchem.2020.00516]
File allegati a questo prodotto
File Dimensione Formato  
Di-Bello_Innovative_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 857.67 kB
Formato Adobe PDF
857.67 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1418417
Citazioni
  • ???jsp.display-item.citation.pmc??? 40
  • Scopus 73
  • ???jsp.display-item.citation.isi??? 68
social impact